We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.75B
AUM Growth
+$24.7M
Cap. Flow
-$74.5M
Cap. Flow %
-4.25%
Top 10 Hldgs %
27.66%
Holding
275
New
15
Increased
70
Reduced
162
Closed
18

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$10.8M
2
WNS
WNS Holdings
WNS
+$9.49M
3
FN icon
Fabrinet
FN
+$8.56M
4
ADMA icon
ADMA Biologics
ADMA
+$6.59M
5
YOU icon
Clear Secure
YOU
+$5.91M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 23.6%
3 Industrials 20.27%
4 Communication Services 5.79%
5 Consumer Staples 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
101
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.67M 0.21%
746,139
-11,909
-2% -$70.5K
DOX icon
102
Amdocs
DOX
$6.22B
$3.66M 0.21%
+40,528
New +$3.69M
RPAY icon
103
Repay Holdings
RPAY
$317M
$3.62M 0.21%
328,910
+78,033
+31% +$690K
PRMW
104
DELISTED
Primo Water Corporation
PRMW
$3.59M 0.2%
196,887
-20,389
-9% -$321K
FIVE icon
105
Five Below
FIVE
$13B
$3.58M 0.2%
19,732
-4,186
-18% -$807K
ICFI icon
106
ICF International
ICFI
$1.66B
$3.54M 0.2%
23,473
-12,885
-35% -$1.87M
ADUS icon
107
Addus HomeCare
ADUS
$2.23B
$3.5M 0.2%
33,872
-6,546
-16% -$612K
GATX icon
108
GATX Corp
GATX
$6.23B
$3.42M 0.2%
25,498
-5,355
-17% -$673K
THR
109
DELISTED
Thermon Group Holdings
THR
$3.41M 0.19%
104,181
-15,468
-13% -$454K
MYRG icon
110
MYR Group
MYRG
$5.14B
$3.4M 0.19%
19,262
+18
+0.1% +$2.77K
SLP icon
111
Simulations Plus
SLP
$371M
$3.39M 0.19%
82,269
-163
-0.2% -$6.68K
IRMD icon
112
iRadimed
IRMD
$1.15B
$3.37M 0.19%
76,711
-166
-0.2% -$7.34K
MTRN icon
113
Materion
MTRN
$5.83B
$3.34M 0.19%
25,344
-2,373
-9% -$301K
TNDM icon
114
Tandem Diabetes Care
TNDM
$1.59B
$3.33M 0.19%
94,140
-10,290
-10% -$276K
RMBS icon
115
Rambus
RMBS
$10.4B
$3.32M 0.19%
53,655
-11,811
-18% -$747K
CCSI icon
116
Consensus Cloud Solutions
CCSI
$680M
$3.31M 0.19%
208,685
-3,819
-2% -$68.4K
ENSG icon
117
The Ensign Group
ENSG
$10.7B
$3.3M 0.19%
26,558
-8,799
-25% -$1.06M
HROW icon
118
Harrow
HROW
$1.52B
$3.24M 0.19%
245,101
+13,637
+6% +$145K
HURN icon
119
Huron Consulting
HURN
$2.42B
$3.21M 0.18%
33,232
+8
+0% +$811
USPH icon
120
US Physical Therapy
USPH
$1.24B
$3.16M 0.18%
28,009
-93
-0.3% -$9.29K
GMED icon
121
Globus Medical
GMED
$11.7B
$3.15M 0.18%
58,705
+12,315
+27% +$662K
LUCK
122
Lucky Strike Entertainment
LUCK
$893M
$3.12M 0.18%
227,791
-25,237
-10% -$326K
LNTH icon
123
Lantheus
LNTH
$6.59B
$3.11M 0.18%
49,982
-11,366
-19% -$669K
VPG icon
124
Vishay Precision Group
VPG
$864M
$3.09M 0.18%
87,504
+61
+0.1% +$2.02K
TRNS icon
125
Transcat
TRNS
$850M
$3.06M 0.17%
27,472
+96
+0.4% +$10.2K

Similar funds

Rice Hall James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Rice Hall James & Associates held 275 positions worth $1.75B, up 1.4% from $1.73B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rice Hall James & Associates withdrew a net $74.5M in Q1 2024, closing 18 positions and reducing 162 holdings. Its most notable exit was PGT, Inc., an estimated $25.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in ADMA Biologics worth $7.96M.

  • Rice Hall James & Associates's largest Q1 2024 buy was ADMA Biologics: 1,206,499 shares worth $7.96M.
  • Rice Hall James & Associates added most to Alkermes in Q1 2024, an estimated $10.8M increase.
  • Rice Hall James & Associates's biggest Q1 2024 reduction was MASONITE INTERNATIONAL CORP, cutting an estimated $10.2M.
  • Rice Hall James & Associates fully exited PGT, Inc. in Q1 2024, selling an estimated $25.4M.
  • Rice Hall James & Associates's ten largest holdings make up 28% of its $1.75B portfolio in Q1 2024.
  • Rice Hall James & Associates opened 15 new positions and closed 18 in Q1 2024.
  • Rice Hall James & Associates's portfolio value rose 1.4% quarter-over-quarter to $1.75B.

Based on Rice Hall James & Associates's 13F filing for Q1 2024, filed 23 Apr 2024.